Skip to main content

Policy/Advocacy

Technology
With opioid overdose deaths and stimulant use on the rise, FDA director Janet Woodcock highlighted for Rx Summit attendees several of the administration’s top initiatives to meet the challenge.
Policy/Advocacy
U.S. Rep. David Trone discussed the merger of his Freshmen Working Group on Addiction with the Bipartisan Opioid Task Force on Thursday at the Rx Summit. Rep. Lori Trahan, meanwhile, said she is reintroducing legislation to standardize SUD training for prescribers.
Evidence-Based Practices
Today’s addiction crisis is not the same as those that preceded it, and while there are reasons for concern, CDC director Rochelle Walensky, MD, MPH, told Rx Drug Abuse & Heroin Summit attendees in a session presented Wednesday morning that she also sees reasons for hope.
Technology
U.S. Rep. Hal Rogers told Rx Summit attendees on Tuesday that PDMPs are a great defense against the nation’s opioid threat, but concerns remain in a number of areas, including the future of Purdue Pharma. Sen. Mitch McConnell and Rep. Tom Cole, meanwhile, said the pandemic has heightened the need to double down in the opioid addiction fight.
Credentialing
An interstate compact that will allow professional counselors who are licensed and reside in one member state to practice in all participating states is closer to being enacted after bills were approved by Georgia and Maryland legislatures.
Policy/Advocacy
Acknowledging that addiction is a crisis that “touches families in every community in red states and blue states, across all races and creeds,” President Joe Biden told Rx Drug Abuse & Heroin Summit attendees in prepared remarks presented on Monday that his administration will face the challenge head-on.
Policy/Advocacy
In his opening remarks at the Rx Drug Abuse & Heroin Summit on Monday, U.S. Rep. Hal Rogers said a multi-pronged approach – law enforcement, treatment and education – remains the best path forward in tackling the opioid crisis.
Policy/Advocacy
Dan Schneider, the subject of a Netflix series that chronicled efforts to track down the individual who killed his son in a drug deal gone bad, has formed a lobbying group to advocate for education, recovery, treatment and research to address the nation’s opioid crisis.
Policy/Advocacy
On Thursday, ONDCP acting director Regina LaBelle unveiled the seven priorities that will guide the Biden administration’s approach to addressing the addiction crisis during its first year in office.
Clinical
The American Society of Addiction Medicine and the American Academy of Addiction Psychiatry are seeking members for a committee to develop clinical practice guidelines for treating stimulant use disorder.
Policy/Advocacy
A new issue brief published by the Brandeis Opioid Resource Connector looks at employment, housing and education, the roles that those domains play in opioid-related outcomes, and program models related to each that are being implemented in communities across the U.S.
Back to Top